Ellen M. van Dam
Teva Pharmaceuticals (Australia)(AU)
Publications by Year
Research Areas
Cellular transport and secretion, Radiopharmaceutical Chemistry and Applications, Neuroendocrine Tumor Research Advances, Pancreatic function and diabetes, Immune Cell Function and Interaction
Most-Cited Works
- → Characterization of the Role of the Rab GTPase-activating Protein AS160 in Insulin-regulated GLUT4 Trafficking(2005)388 cited
- → Dynamin-dependent Transferrin Receptor Recycling by Endosome-derived Clathrin-coated Vesicles(2002)221 cited
- → GLUT4 Recycles via atrans-Golgi Network (TGN) Subdomain Enriched in Syntaxins 6 and 16 But Not TGN38: Involvement of an Acidic Targeting Motif(2003)212 cited
- → Endocytosed Transferrin Receptors Recycle via Distinct Dynamin and Phosphatidylinositol 3-Kinase-dependent Pathways(2002)147 cited
- → Reproducibility of goniometric measurement of the knee in the in-hospital phase following total knee arthroplasty(2007)132 cited
- → Akt Activation Is Required at a Late Stage of Insulin-Induced GLUT4 Translocation to the Plasma Membrane(2005)116 cited
- → Myristyl Trimethyl Ammonium Bromide and Octadecyl Trimethyl Ammonium Bromide Are Surface-Active Small Molecule Dynamin Inhibitors that Block Endocytosis Mediated by Dynamin I or Dynamin II(2007)116 cited
- → 45‐Hour continuous quintuple‐site actimetry: Relations between trunk and limb movements and effects of circadian sleep‐wake rhythmicity(1997)90 cited
- → Ral: Mediator of membrane trafficking(2006)86 cited
- → Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model(2020)67 cited